Heranova: Detecting endometriosis in the blood like it’s cancer
The Massachusetts-based company launched a microRNA-based liquid biopsy test for endometriosis, with an eye toward disease monitoring and drug development
Heranova thinks the similarities between endometriosis and cancer will make the notoriously difficult-to-diagnose disease amenable to non-invasive detection via liquid biopsy of nucleic acids from uterine lining cells undergoing excessive growth, which opens to door to use cases beyond yes/no diagnoses.
“Endometriosis behaves like a cancer,” Farideh Bischoff, CMO and head of diagnostics at Burlington, Mass-based Heranova Lifesciences Inc., told BioCentury. “The mechanisms by which this disease progresses and develops results in the shedding of material in the blood.” ...
BCIQ Company Profiles